ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
ARTELO BIOSCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Aug 20, 2026
$2.66−0.04 (-1.48%)
Close on Oct 19, 2026
- Market cap
- $7.21M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Artelo Biosciences's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Armistice Capital, LLC | 235,823 | 9.99% | 13G (passive) | Mar 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Gregory D. Gorgas | Pres, CEO, CFO, Treas & Secr, Director | 273,076 | 5.94% | Feb 2, 2026 |
| Mark Edward Spring | Chief Financial Officer | – | – | Feb 2, 2026 |
| Tamara A. Favorito | Director | – | – | Jul 21, 2026 |
| Robert Martin Emanuele | Director | 12,500 | 0.27% | Jul 21, 2026 |
| Steven Kelly | Director | 12,500 | 0.27% | Jul 21, 2026 |
| Douglas Blayney | Director | 12,500 | 0.27% | Jul 21, 2026 |
| Gregory Reyes | Director | – | – | Jul 21, 2026 |
| Connie Matsui | Director | 56,667 | 1.23% | Jul 21, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Gregory D. Gorgas Pres, CEO, CFO, Treas & Secr, Director | Aug 12, 2022 | Buy | +1,200 | $4.00 | $4.80K | 2,400 |
| Gregory D. Gorgas Pres, CEO, CFO, Treas & Secr, Director | Aug 11, 2022 | Buy | +1,200 | $4.03 | $4.84K | 1,200 |
| Gregory D. Gorgas Pres, CEO, CFO, Treas & Secr, Director | Apr 16, 2021 | Buy | +8,500 | $1.15 | $9.78K | 270,676 |
| Gregory D. Gorgas Pres, CEO, CFO, Treas & Secr, Director | May 15, 2020 | Buy | +4,200 | $1.21 | $5.08K | 262,176 |
| Gregory D. Gorgas Pres, CEO, CFO, Treas & Secr, Director | May 4, 2020 | Buy | +4,167 | $1.20 | $5.00K | 257,976 |
| Connie Matsui Director | May 4, 2020 | Buy | +41,667 | $1.20 | $50.00K | 56,667 |
| Gregory D. Gorgas Pres, CEO, CFO, Treas & Secr, Director | Nov 4, 2019 | Buy | +2,400 | $2.21 | $5.30K | 253,809 |
| Gregory D. Gorgas Pres, CEO, CFO, Treas & Secr, Director | Nov 1, 2019 | Buy | +2,500 | $2.28 | $5.70K | 251,409 |
| Gregory D. Gorgas Pres, CEO, CFO, Treas & Secr, Director | Oct 31, 2019 | Buy | +2,500 | $1.95 | $4.88K | 248,909 |
| Gregory D. Gorgas Pres, CEO, CFO, Treas & Secr, Director | Oct 30, 2019 | Buy | +2,600 | $1.99 | $5.17K | 246,409 |
| Gregory D. Gorgas Pres, CEO, CFO, Treas & Secr, Director | Oct 15, 2019 | Buy | +2,600 | $2.05 | $5.33K | 243,809 |
| Gregory D. Gorgas Pres, CEO, CFO, Treas & Secr, Director | Oct 11, 2019 | Buy | +2,700 | $1.96 | $5.29K | 241,209 |
| Peter Michael O'Brien 10% owner | Sep 4, 2019 | Other | −17,500 | – | – | 7,500 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.